BioRem Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CAD 25.17 million compared to CAD 28.86 million a year ago. Net income was CAD 2.18 million compared to CAD 1.61 million a year ago.

Basic earnings per share from continuing operations was CAD 0.14 compared to CAD 0.1 a year ago. Diluted earnings per share from continuing operations was CAD 0.13 compared to CAD 0.09 a year ago.